1-2 of 2
Todd Yezefski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rates of CR with and without Measurable Residual Disease after Induction Treatment with "7+3" or Azacitidine/Decitabine for Newly-Diagnosed AML

Todd Yezefski, MD, Roland B. Walter, MD PhD, Pamela S. Becker, MD PhD, Paul C. Hendrie, MD PhD, Vivian Oehler, MD, Mary-Elizabeth M. Percival, MD MS, Elihu H. Estey, MD
Journal: Blood
Blood (2016) 128 (22): 2792.
https://doi.org/10.1182/blood.V128.22.2792.2792
Published: 2016
Journal Articles

Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice

Brief Report
Donald J. McCrann, Todd Yezefski, Hao G. Nguyen, Nicholas Papadantonakis, Hui Liu, Qiang Wen, John D. Crispino, Katya Ravid
Journal: Blood
Blood (2008) 111 (8): 4092–4095.
https://doi.org/10.1182/blood-2007-11-122150
Published: 2008
Includes: Supplemental data